Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more

CYDY Insider Trading (CytoDyn)

Insider Ownership Percentage: 7.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $5,822,290.73

CytoDyn Insider Trading History Chart

This chart shows the insider buying and selling history at CytoDyn by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CytoDyn Share Price & Price History

Current Price: $2.29
Price Change: Price Decrease of -0.03 (-1.29%)
As of 09/27/2021 01:00 AM ET

This chart shows the closing price history over time for CYDY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
717% Since May 2019?!
Members had the chance to more than 10X their TOTAL PORTFOLIOS by following our recommendations since May 2019...

That's why for one week you can join us as we analyze the market LIVE...

And get all our market intelligence and real-time trading recommendations...

Just RSVP Here (No Cost, No Obligation).
Learn more.
pixel

CytoDyn Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2020Michael D MulhollandCFOSell1,104,799$5.27$5,822,290.73
See Full Table
Insider Buying at CytoDyn?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for CytoDyn and related companies.

SEC Filings (Institutional Ownership Changes) for CytoDyn (OTCMKTS:CYDY)

0.14% of CytoDyn stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

CytoDyn Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/15/2016Brookstone Capital Management0$00.0%-100.0%0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CytoDyn logo
CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, Cancer, graft-versus-host disease (GVHD), and COVID-19. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
Read More on CytoDyn

Today's Range

Now: $2.29
Low: $2.26
High: $2.43

50 Day Range

MA: $1.57
Low: $1.28
High: $2.46

52 Week Range

Now: $2.29
Low: $1.25
High: $7.40

Volume

1,305,576 shs

Average Volume

3,306,147 shs

Market Capitalization

$1.48 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of CytoDyn?

CytoDyn's top insider investors include:
  1. Michael D Mulholland (CFO)
Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more